{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidnitnfnjftwhfdvrrsapxo5fadaww5zp5x2wlcskkxaefmfyqe3q",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3melsjcxp4bh2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigzztbjhkoipqr67hfm7mksonmqnk4kpwbiui5frmeb35l2rcwtxe"
    },
    "mimeType": "image/jpeg",
    "size": 431497
  },
  "path": "/news/2026-02-fragile-uncovers-brainwave-biomarker-bridging.html",
  "publishedAt": "2026-02-11T10:20:04.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Neuroscience"
  ],
  "textContent": "Numerous potential treatments for neurological conditions, including autism spectrum disorders, have worked well in lab mice but then disappointed in humans. What would help is a noninvasive, objective readout of treatment efficacy that is shared in both species. In a new study in Nature Communications, a team of MIT researchers backed by collaborators across the United States and in the United Kingdom identifies such a biomarker in fragile X syndrome, the most common inherited autism form.",
  "title": "Fragile X study uncovers brainwave biomarker bridging humans and mice"
}